
About Natural Biocon (India) Limited
Data last updated:
Natural Biocon (India) Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the agricultural products distribution segment of the agriculture sector. It was incorporated on 27 August 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24299GJ1992PLC018210. Its GSTIN is 24AAACN6841K1ZD (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 543207.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹25.78 Cr. It is led by directors including Arunkumar Dashrathbhai Prajapati (Managing Director) and Bhaskar Waman Vishe.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 1007 Sankalp Iconic Opp. Vikram Nagar Iscon Temple Cross Road S. G. Highway, Ahmedabad, Gujarat, India – 380054.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹2.55 Cr, a decline of 69.5% compared to the previous year. For the same year it recorded a net loss of ₹3 Lakh (net margin -1.2%) and EBITDA of -₹3 Lakh (EBITDA margin -1.2%).
The company is associated with 1 brand: Natural Biocon. The company has 229 deals on record (229 market trades); the latest was in August 2026. Its 4 peer companies in the Agriculture industry (Agro Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger; the largest is Ikigai Ventures Private Limited with revenue of ₹1.26 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website naturalbiocon.in.
Company details
CIN history
Natural Biocon (India) has one previous CIN (Corporate Identification Number): U24299GJ1992PLC018210. The current CIN is L24299GJ1992PLC018210, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24299GJ1992PLC018210 | Current |
| U24299GJ1992PLC018210 | Previous |
Contact details
Natural Biocon (India) Limited's registered office is in Ahmedabad, Gujarat. Its website is naturalbiocon.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1007 Sankalp Iconic Opp. Vikram Nagar Iscon Temple Cross Road S. G. Highway, Ahmedabad, Gujarat, India – 380054
- IndustryAgriculture, Agro Retail & Distribution
To see the full contact details of Natural Biocon (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Natural Biocon (India) operates one associated brand: Natural Biocon. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Natural food colorants, chemicals, and agricultural products are manufactured. | naturalbiocon.com |
Business activity
The main business activity of Natural Biocon (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Natural Biocon (India) Limited, buy the company report.
Financials of Natural Biocon (India) Limited
FY 2025-26 filings availableNatural Biocon (India) Limited reported revenue of ₹2.55 Cr (down 69.5% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2.55 | 8.35 | 13.53 | 1.25 | 0.48 | 0.13 | 0.00 |
| Revenue growth | -69.5% | -38.3% | +982.4% | +160.4% | +269.2% | - | - |
| EBITDA | (0.03) | 0.07 | 0.23 | 0.24 | 0.09 | 0.00 | (0.04) |
| EBITDA margin | -1.2% | +0.8% | +1.7% | +19.2% | +18.8% | 0.0% | - |
| Profit before tax | (0.03) | 0.07 | 0.23 | 0.24 | 0.09 | 0.00 | (0.04) |
| Net profit | (0.03) | 0.05 | 0.16 | 0.17 | 0.07 | 0.00 | (0.09) |
| Net profit margin | -1.2% | +0.6% | +1.2% | +13.6% | +14.6% | 0.0% | - |
| EPS (₹) | (0.02) | 0.02 | 0.13 | 0.16 | 0.06 | 0.00 | (0.07) |
| Balance sheet | |||||||
| Total assets | - | 32.15 | 12.45 | 12.38 | 12.21 | 12.34 | 12.66 |
| Net worth | - | 31.87 | 12.38 | 12.23 | 12.05 | 11.98 | 11.98 |
| Total debt | - | 0.28 | 0.07 | 0.15 | 0.16 | 0.36 | 0.68 |
| Cash & bank | - | 0.05 | 0.19 | 0.40 | 0.21 | 0.04 | 0.03 |
| Net working capital | - | 0.68 | 2.07 | 1.03 | 0.84 | 1.76 | 1.84 |
| Cash flow | |||||||
| Cash from operations | - | 1.30 | (0.12) | 0.21 | 0.18 | 0.32 | 0.15 |
| Cash from investing | - | (21.11) | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 |
| Cash from financing | - | 19.67 | (0.09) | (0.02) | 0.00 | (0.32) | (0.14) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.88 | 0.00 | 0.00 | 1.67 | 1.35 | 1.28 | 4.74 |
| Revenue growth (YoY) | -100.0% | -34.8% | -100.0% | -100.0% | +68.7% | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 0.01 | 0.97 | 0.04 | 0.04 | 1.53 | 1.84 | 1.03 | 4.53 |
| EBITDA | (0.01) | (0.09) | (0.04) | (0.04) | 0.14 | (0.49) | 0.25 | 0.21 |
| EBITDA margin | - | -10.2% | - | - | +8.4% | -36.3% | +19.5% | +4.4% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.01) | (0.09) | (0.04) | (0.04) | 0.14 | (0.49) | 0.25 | 0.21 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.88 | 0.00 | 0.00 | 1.67 | 1.35 | 1.28 | 4.74 |
| Revenue growth (YoY) | -100.0% | -34.8% | -100.0% | -100.0% | +68.7% | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 0.01 | 0.97 | 0.04 | 0.04 | 1.53 | 1.84 | 1.03 | 4.53 |
| EBITDA | (0.01) | (0.09) | (0.04) | (0.04) | 0.14 | (0.49) | 0.25 | 0.21 |
| EBITDA margin | - | -10.2% | - | - | +8.4% | -36.3% | +19.5% | +4.4% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.01) | (0.09) | (0.04) | (0.04) | 0.14 | (0.49) | 0.25 | 0.21 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.55 | 8.35 | 13.53 | 1.25 | 0.48 | 0.13 | 0.00 |
| Revenue growth | -69.5% | -38.3% | +982.4% | +160.4% | +269.2% | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 2.58 | 8.28 | 13.30 | 1.01 | 0.39 | 0.13 | 0.04 |
| Employee cost | 0.00 | 0.32 | 0.19 | 0.05 | 0.02 | 0.01 | 0.02 |
| EBITDA | (0.03) | 0.07 | 0.23 | 0.24 | 0.09 | 0.00 | (0.04) |
| EBITDA margin | -1.2% | +0.8% | +1.7% | +19.2% | +18.8% | 0.0% | - |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.03) | 0.07 | 0.23 | 0.24 | 0.09 | 0.00 | (0.04) |
| Tax | 0.00 | 0.02 | 0.07 | 0.07 | 0.02 | 0.00 | 0.05 |
| Net profit | (0.03) | 0.05 | 0.16 | 0.17 | 0.07 | 0.00 | (0.09) |
| Net profit margin | -1.2% | +0.6% | +1.2% | +13.6% | +14.6% | 0.0% | - |
| EPS (₹) | (0.02) | 0.02 | 0.13 | 0.16 | 0.06 | 0.00 | (0.07) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 25.78 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 |
| Reserves & surplus | - | 6.09 | 1.01 | 0.86 | 0.68 | 0.61 | 0.61 |
| Shareholders' funds (net worth) | - | 31.87 | 12.38 | 12.23 | 12.05 | 11.98 | 11.98 |
| Secured loans | - | 0.28 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | - | 0.00 | 0.00 | 0.15 | 0.16 | 0.36 | 0.68 |
| Total debt | - | 0.28 | 0.07 | 0.15 | 0.16 | 0.36 | 0.68 |
| Total liabilities | - | 32.15 | 12.45 | 12.38 | 12.21 | 12.34 | 12.66 |
| Assets | |||||||
| Gross block | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Net block | - | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Capital work in progress | - | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
| Investments | - | 21.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | - | 0.17 | 0.16 | 0.92 | 0.06 | 0.06 | 0.06 |
| Sundry debtors | - | 5.66 | 4.87 | 0.63 | 0.49 | 0.52 | 0.62 |
| Cash & bank balances | - | 0.05 | 0.19 | 0.40 | 0.21 | 0.04 | 0.03 |
| Loans & advances | - | 1.17 | 1.17 | 0.21 | 0.17 | 1.18 | 1.18 |
| Total current assets | - | 7.05 | 6.39 | 2.16 | 0.93 | 1.80 | 1.89 |
| Total current liabilities | - | 6.37 | 4.32 | 1.13 | 0.09 | 0.04 | 0.05 |
| Net working capital | - | 0.68 | 2.07 | 1.03 | 0.84 | 1.76 | 1.84 |
| Total assets | - | 32.15 | 12.45 | 12.38 | 12.21 | 12.34 | 12.66 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 0.19 | 0.40 | 0.21 | 0.04 | 0.03 | 0.03 |
| Net cash from operating activities | - | 1.30 | (0.12) | 0.21 | 0.18 | 0.32 | 0.15 |
| Net cash from investing activities | - | (21.11) | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 |
| Net cash from financing activities | - | 19.67 | (0.09) | (0.02) | 0.00 | (0.32) | (0.14) |
| Net change in cash | - | (0.14) | (0.21) | 0.19 | 0.17 | 0.00 | 0.01 |
| Closing cash | - | 0.05 | 0.19 | 0.40 | 0.21 | 0.04 | 0.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -69.5% | -38.3% | +982.4% | +160.4% | +269.2% | - | - |
| EBITDA growth | -142.9% | -69.6% | -4.2% | +166.7% | - | +100.0% | - |
| PBT growth | - | -69.6% | -4.2% | +166.7% | +9997.0% | +9997.0% | - |
| Net income growth | -160.0% | -68.8% | -5.9% | +142.9% | - | +100.0% | - |
| Revenue CAGR (3Y) | +26.8% | +159.1% | +370.4% | - | +2.2% | -50.0% | -100.0% |
| EBITDA CAGR (3Y) | - | -8.0% | - | - | -9.1% | -100.0% | - |
| Profitability & leverage | |||||||
| Net income margin | -1.2% | +0.6% | +1.2% | +13.6% | +14.6% | 0.0% | - |
| Return on capital employed | - | +0.3% | +1.8% | +2.0% | +0.7% | 0.0% | -0.2% |
| Return on net worth | - | +0.2% | +1.2% | +1.5% | +0.6% | 0.0% | -0.7% |
| Debt / equity | - | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | 0.06 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 835.00 | 1,353.00 | 125.00 | 96.00 | 0.00 | 0.00 |
| Inventory turnover | - | 50.61 | 25.06 | 2.55 | 8.00 | 2.17 | 0.00 |
| Debtors turnover | - | 1.59 | 4.92 | 2.23 | 0.95 | 0.23 | 0.00 |
| EPS (₹) | (0.02) | 0.02 | 0.13 | 0.16 | 0.06 | 0.00 | (0.07) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 12.36 | 10.89 | 10.75 | 10.60 | 10.54 | 10.54 |
To see the full year-wise statements and ratios of Natural Biocon (India) Limited, buy the company report.
Board of directors of Natural Biocon (India) Limited
Natural Biocon (India) has 4 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaskar Waman Vishe | Director | 23 Oct 2021 | 5 Years 0 Months | Current |
| Suryakant Govind Lohar Also directs: Rich Pockets Online Services Limited | Director | 23 Oct 2021 | 5 Years 0 Months | Current |
| Darshangi Manish Patel Also directs: Western Agrotech Innovative Limited | Director | 01 Nov 2021 | 5 Years 0 Months | Current |
| Arunkumar Dashrathbhai Prajapati | Managing Director | 21 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Natural Biocon (India) Limited is compared with the 4 companies closest to it by revenue in the Agriculture industry (Agro Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Natural Biocon (India) Limitedthis company | ₹2.55 Cr (FY 2026) | -₹3 Lakh | -1.2% | -69.5% | Ahmedabad, Gujarat, India | |
| Ikigai Ventures Private Limited | ₹1.26 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Nemchand Jain & Sons Private Limited | ₹1.26 Cr (FY 2024) | 33.0% | Siliguri, West Bengal, India | |||
| Adivasi Nari Utthan Ajivika Producer Company Limited | ₹1.25 Cr (FY 2025) | 18.0% | Eastsinghbhum, Jharkhand, India | |||
| Mahananda Tea Processing Private Limited | ₹1.25 Cr (FY 2024) | -17.0% | Islampur, West Bengal, India |
To see the full peer comparison of Natural Biocon (India) Limited, buy the company report.
Shareholding
The shareholding of Natural Biocon (India) Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Natural Biocon (India) Limited, buy the company report.
Deals & funding
Natural Biocon (India) Limited has 229 deals on record (229 market trades); the latest was in August 2026.
Deals on record (5 of 229)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2025 | Market trade | ₹62.3 Lakh | Buyer: an individual Seller: Lovekesh Huf, Neo Apex Venture LLP |
| Aug 2025 | Market trade | ₹15.1 Lakh | Seller: Neo Apex Venture LLP |
| Aug 2025 | Market trade | ₹1.89 Cr | Buyer: Motilal Oswal Financial Services Limited-Error Account, Neo Apex Venture LLP , Lovekesh Huf, an individual Seller: Motilal Oswal Financial Services Limited-Error Account, Neo Apex Venture LLP , an individual |
| Jul 2025 | Market trade | ₹77.8 Lakh | Buyer: 2 individuals Seller: Chaubara Eats Private Limited , 3 individuals |
| Jun 2025 | Market trade | ₹43 Lakh | Buyer: an individual Seller: Copo Holdings Private Limited , an individual |
To see the full deal history of Natural Biocon (India) Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Natural Biocon (India) Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Natural Biocon (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Natural Biocon (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACN6841K1ZD | Gujarat | Active | 19 Mar 2018 |
To see the full GST registrations and return filing status of Natural Biocon (India) Limited, buy the company report.
Recent activity
Natural Biocon (India) Limited has 20 board changes on record since 1992: 12 appointments and 8 cessations. The latest: Manish Rameshbhai Patel ceased to be Director on 27 Apr 2024.
11 earlier events are in the company report.
News
Frequently asked questions
Natural Biocon (India) is an active public limited company based in Ahmedabad, Gujarat, India. The company works in agro retail and distribution, within the agriculture industry. It was incorporated on 27 August 1992 (34+ years old) and is registered under CIN L24299GJ1992PLC018210. Listed on BSE: 543207.
Natural Biocon (India) reported revenue of ₹2.55 Cr for FY 2025-26 (down 69.5% YoY) based on standalone financials.
Natural Biocon (India) has 4 current directors:
- Arunkumar Dashrathbhai Prajapati - Managing Director
- Bhaskar Waman Vishe - Director
- Suryakant Govind Lohar - Director
- Darshangi Manish Patel - Director
The latest financial statements of Natural Biocon (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Natural Biocon (India) is 24AAACN6841K1ZD, registered in Gujarat.
The CIN (Corporate Identification Number) of Natural Biocon (India) is L24299GJ1992PLC018210. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Natural Biocon (India) is a listed company as per MCA records. Its shares are listed on BSE (code: 543207).
Natural Biocon (India) was incorporated on 27 August 1992, making it 34+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Natural Biocon (India) has 229 deals on record (229 market trades); the latest was in August 2026.
The peers of Natural Biocon (India) by revenue are Ikigai Ventures Private Limited, Nemchand Jain & Sons Private Limited, Adivasi Nari Utthan Ajivika Producer Company Limited, Mahananda Tea Processing Private Limited, all in the Agriculture industry (Agro Retail and Distribution), with the same principal business activity (wholesale trading).
Manish Rameshbhai Patel ceased to be Director on 27 Apr 2024. Arunkumar Dashrathbhai Prajapati was appointed as Managing Director on 21 Feb 2022. Darshangi Manish Patel was appointed as Director on 01 Nov 2021. Natural Biocon (India) has 20 board changes on record in total.

